Relypsa Inc (NASDAQ:RLYP)

23.68
Data as of Jul 30
 +0.56 / +2.42%
Today’s Change
11.55
Today|||52-Week Range
52.74
-5.28%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$782.5M

Company Description

Relypsa, Inc. operates as a clinical-stage pharmaceutical company focused on the development and commercialization of non absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed potassium binder for the treatment of hyperkalemia and RLY6002, polymer drug discovery technology. The company was founded on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Information

Relypsa, Inc.
700 Saginaw Drive
Redwood City California 94063
P:(650) 421-9500
Investor Relations:

Employees

Shareholders

Individual stakeholders48.27%
Other institutional37.28%
Mutual fund holders14.24%

Top Executives

John A. OrwinPresident, Chief Executive Officer & Director
Wilhelm StahlSenior Vice President-Pharmaceutical Operations
Kristine McClintock BallChief Financial Officer & Senior Vice President
Jerry M. BuysseChief Scientific Officer & Senior VP-Research
Lance BermanChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.